The latest randomized controlled trial on the standard treatment of IESS reported that, at 30 days after two-week treatment, 9/12 (75%) of the IESS children were controlled with ACTH, 1/9 (11%) with vigabatrin and 5/13 (38%) with combined therapy [15]. The gene discussed is POMC; the disease is infantile spasms.